Affluent Medical to acquire Caranx Medical and Artedrone, become Carvolix

Affluent Medical entered binding agreements to acquire Caranx Medical and Artedrone for €16.6M and €11.4M respectively, paid in shares. The combined entity will be named Carvolix, focusing on cardiovascular therapies with AI-driven mini-robots and implants.

“Affluent Medical announces upcoming acquisition of Caranx Medical and Artedrone, becoming Carvolix, pioneering cardiovascular therapies with AI driven autonomous mini-robots and innovative implants.”tradingview.com

• 2 sources
• tradingview.comAffluent Medical announces upcoming acquisition of Caranx Medical and Artedrone, becoming Carvolix, pioneering cardiovascular therapies. — TradingView NewsDec 19, 2025
• massdevice.comAffluent Medical to acquire Caranx, ArtedroneSean WhooleyDec 22, 2025

Summarized from public sources; check the original articles before acting on it.